Brompheniramine, Pseudoephedrine, Dextromethorphan Syrup
NDC Package 67877-558-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Brompheniramine, Pseudoephedrine, Dextromethorphan syrups is for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. This formulation utilizes a syrup delivery system. Marketed by Ascend Laboratories, Llc, this product is identified by NDC 67877-558 and is authorized under FDA application ANDA210647.

Identification & Billing

NDC Package Code
67877-558-16
Package Description
473 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
67877055816
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk
  • RxCUI: 1357010 - brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution
  • RxCUI: 1357010 - brompheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
  • RxCUI: 1357010 - brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / pseudoephedrine HCl 30 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Brompheniramine, Pseudoephedrine, Dextromethorphan
Non-Proprietary Name
Brompheniramine, Pseudoephedrine, Dextromethorphan
Substance Name
Brompheniramine Maleate; Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
For relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.

Regulatory & Marketing

Labeler Name
Ascend Laboratories, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA210647
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-05-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67877-558). Click a package code to view its specific billing and regulatory data.

118 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67877-558-16 identifies a specific commercial package of 473 ml in 1 bottle of Brompheniramine, Pseudoephedrine, Dextromethorphan, a human prescription drug labeled by Ascend Laboratories, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This syrup is formulated for oral use and contains brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ascend Laboratories, Llc on January 05, 2026. The current certification is valid through December 31, 2027.

How is this Ascend Laboratories, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67877055816. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67877-558-16
11-Digit CMS (5-4-2)
67877-0558-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.